Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 43,736 shares at $8.14 ($362K) on 2016-05-10, disclosed to the SEC on 2016-05-12.
Open-market sale of $362k KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.14 | 20,000 | $163K | 44.9% |
| 2 | $8.41 | 11,868 | $100K | 27.5% |
| 3 | $8.41 | 11,868 | $100K | 27.5% |
| Total | $8.29 avg | 43,736 | $362K | 100% |
| Filing → |
| KPTI | SELL | 2018-07-23 | $4.8M | — | Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |